BusinessRich Pharmaceuticals Explains How Targeted Immunotherapy Aids in the Treatment and Recovery of AML PatientsBy Nasdaq OMXApr 10, 2018, 11:01 AM UTC
BusinessRhizen Pharmaceuticals S.A. announces preclinical data presentations for RP4010, a calcium release-activated calcium (CRAC) channel inhibitor and RP10107, a glutaminase inhibitor at the 2018 AACR Annual MeetingBy Nasdaq OMXApr 10, 2018, 11:00 AM UTC
BusinessAdaptimmune to Present Two Posters at the Upcoming American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXApr 6, 2018, 12:00 PM UTC
BusinessFriends, Family and Co-Workers Form Teams to Support Those Affected by Ovarian Cancer at Jodi’s Race for AwarenessBy Nasdaq OMXApr 3, 2018, 4:07 PM UTC
BusinessGalectin Therapeutics to Present at H.C. Wainwright Global Life Sciences ConferenceBy Nasdaq OMXApr 2, 2018, 2:20 PM UTC
BusinessUnum Therapeutics Announces Pricing of Initial Public OfferingBy Nasdaq OMXMar 29, 2018, 1:35 AM UTC
BusinessSpotlight Innovation Subsidiary Celtic Biotech Iowa to Present Two Posters at 2018 American Association for Cancer Research (AACR) Annual MeetingBy Nasdaq OMXMar 28, 2018, 1:01 PM UTC
